期刊文献+

重组AQP9对L-02细胞脂质沉积的影响 被引量:6

Effect of recombinant AQP9 on lipid deposition in L-02 cells
原文传递
导出
摘要 目的构建人水甘油通道蛋白9(aquaglyceroporin9,AQP9)重组质粒,验证其在L-02肝细胞中的表达,并检测其对非酒精性脂肪肝病(nonalcoholic fatty liver disease,NAFLD)细胞模型的作用。方法从人肝脏组织中提取总RNA,RT-PCR获得AQP9基因,克隆到载体pEGFP-N1上,构建重组质粒pEGFP-N1-AQP9。将其转染L-02细胞,通过荧光显微镜观察其转染情况,RT-PCR和Western blot检测AQP9基因在细胞中的表达。通过油红O染色,测定甘油三酯、游离脂肪酸及甘油含量,检测其对L-02细胞脂肪变性模型的作用。结果成功构建pEGFP-N1-AQP9重组质粒,并能在L-02细胞中表达,将其转染L-02细胞脂肪变性模型后,油红O染色可见油酸/pEGFP-N1-AQP9转染组较油酸组细胞内脂质含量明显升高,油酸/pEGFP-N1-AQP9转染组细胞内甘油三酯、游离脂肪酸及甘油含量分别为(5.435±0.337)、(2.016±0.144)、(1.485±0.113)mmol/L,而油酸组分别为(3.218±0.220)、(1.538±0.193)、(1.024±0.148)mmol/L,两者之间差异有统计学意义(P<0.01),说明上调AQP9表达量可使其脂肪变性程度加重。结论 AQP9异常升高能够引起或加重非酒精性脂肪肝病。 Objective To construct a recombinant plasmid of human aquaglyceroporin 9(AQP9),to examine its expression in liver cell L-02 and to detect its effect on cellular models of nonalcoholic fatty liver disease(NAFLD).Methods Total mRNA was extracted from human hepatic tissues,and human AQP9 gene was amplified by RT-PCR.AQP9 gene was then inserted into pEGFP-N1 to construct recombinant plasmid pEGFP-N1-AQP9,which was transfected into L-02 cells.The transfection was detected by fluorescent microscopy,and the expression of AQP9 gene was detected by RT-PCR and Western blotting.The effect of AQP9 on NAFLD cellular models was examined by oil red O staining and the determination of triglycerides(TG),free fatty acids(FFAs) and glycerol contents.Results Recombinant plasmid pEGFP-N1-AQP9 was successfully constructed,and AQP9 expression could be detected after L-02 cells were transfected with pEGFP-N1-AQP9.The oil red O staining showed that the intracellular lipid contents were significantly higher in the oleic acid/pEGFP-N1-AQP9 group than in the oleic acid group(P0.01).The intracellular TG,FFAs and glycerol contents in the oleic acid/pEGFP-N1-AQP9 group were 5.435±0.337,2.016±0.144 and 1.485±0.113 mmol/L,respectively,while those in the oleic acid group were 3.218±0.220,1.538±0.193 and 1.024±0.148 mmol/L,respectively.It indicated that the upregulation of AQP9 could aggravate the degree of steatosis.Conclusion AQP9 abnormal upregulation can lead to or aggravate NAFLD.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第17期1722-1726,共5页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81070318) 重庆市卫生局医学科学技术研究项目(渝卫科教2010-2-100)~~
关键词 水甘油通道蛋白9 非酒精性脂肪肝病 重组质粒 基因治疗 aquaglyceroporin 9 nonalcoholic fatty liver disease recombinant vector gene therapy
  • 相关文献

参考文献15

  • 1Kim H K, Park J Y, Lee K U, et al. Effect of body weight and lifes- tyle changes on long-term course of nonalcoholic fatty liver disease in Koreans[J]. Am J Med Sci, 2009, 337(2) : 98 - 102.
  • 2Hjelkrem M C, Torres D M, Harrison S A. Nonalcoholic fatty liver dis- ease[J]. Minerva Med, 2008, 99(6) : 583 -593.
  • 3Jelen S, Wacker S, Aponte-Santamaria C, et al. Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeo- genesis in mice[J]. J Biol Chem, 2011,286(52) : 44319 -44325.
  • 4Rojek A M, Skowronski M T, Fuchtbauer E M, et al. Defective glyc- erol metabolism in aquaporin 9 (AQP9) knockout mice [ J ]. Proc Natl Acad Sci U S A, 2007, 104(9) : 3609 -3614.
  • 5王万东,陈东风.非酒精性脂肪变性肝细胞模型中ATF4基因的表达及其意义[J].第三军医大学学报,2010,32(14):1487-1490. 被引量:4
  • 6Serfaty L, Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis[ J]. Diabe- tes Metab, 2008, 34 (6 Pt 2) : 634 -637.
  • 7邱烈旺,顾陆昀,吕琳,王奎,梅浙川.水甘油通道蛋白在非酒精性脂肪变性肝细胞模型中的表达及意义[J].第三军医大学学报,2012,34(7):622-626. 被引量:11
  • 8Hara-Chikuma M, Verkman A S. Physiological roles of glycerol-trans- porting aquaporins: the aquaglyceroporins [ J ]. Cell Mol Life Sci, 2006, 63(12) : 1386 -1392.
  • 9Maeda N, Hibuse T, Funahashi T. Role of aquaporin-7 and aquaporin- 9 in glycerol metabolism; involvement in obesity[J]. Handb Exp Phar- macol, 2009, (190) : 233 -249.
  • 10Miranda M, Ceperuelo-Mallafre V, Lecube A, et al. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity : relationship with glucose abnormalities [ J ]. Metabo- lism, 2009, 58(12) : 1762 - 1768.

二级参考文献21

  • 1艾正琳,陈东风.SREBP-1c在大鼠非酒精性脂肪性肝病中的表达及意义[J].第三军医大学学报,2006,28(10):1063-1065. 被引量:36
  • 2杨林辉,陈东风.油酸诱导培养肝细胞脂肪变性模型的建立[J].重庆医学,2007,36(8):698-700. 被引量:29
  • 3Masyuk AI,LaRusso NF.Aquaporins in the bepatobiliary system.Hepatology,2006,43(2 Suppl 1):S75-81.
  • 4Elkjaer M,Vajda Z,Nejsum LN,et al.Immunolocalization of AQP9 in liver,epididymis,testis,spleen,and brain.Biochem Biophys Res Commun,2000,276:1118-1128.
  • 5Zhang J,Ou J,Bashmakov Y,et al.Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes.Proc Natl Acad Sci USA,2001,98:3756-3761.
  • 6Zhang W,Patil S,Chauhan B,et al.FoxO1 regulates multiple metabolic pathways in the liver:effects on gluconeogenic,glycolytic,and lipogenic gene expression.J Biol Chem,2006,281:10105-10117.
  • 7[S]Chapman MJ.Metabolic syndrome and type 2 diabetes:lipid and physiological consequences.Diab Vase Dis Res,2007,4 Suppl 3:S5-8.
  • 8Reshef L,Olswang Y,Cassuto H,et al.Glyceroneogenesis and the triglyceride/fatty acid cycle.J Biol Chem,2003,278:30413-30416.
  • 9Kuriyama H,Shimomura I,Kishida K,et al.Coordinated regulation of fat-specific and liver-specific glycerol channels,aquaporin adipose and aquaporin 9.Diabetes,2002,51:2915-2921.
  • 10Carbrey JM,Gorelick-Feldman DA,Kozono D,et al.Aquaglyceroporin AQP9:solute permeation and metabolic control of expression in liver.Proc Natl Acad Sci U S A,2003,100:2945-2950.

共引文献17

同被引文献74

  • 1沈峰,丁晓东,范建高.2012美国非酒精性脂肪性肝病诊疗指南简介[J].中国医学前沿杂志(电子版),2012,4(7):11-13. 被引量:33
  • 2Carbrey J M, Gorelick-Feldman D A, Kozono D A, et al. Aquaglyceropofin AQP9:solute permeation and metabolic control of expression in liver [ J ]. Proc Natl Acad Sci USA ,2003,100( 5 ) :2945. gA .
  • 3Rojek A M, Skowronski M T, Fuchtbauer E M, et al. Defective glycerol metabolism in aquaporin 9 ( AQP9 ) knockout mice [ J ]. Proc Natl Acad Sci USA, 2007,104 (8) :3609.
  • 4Rojek A, Praetorius J, Frokiaer J, et ol. A current view of the mam- malian aquaglyeeroporins J ]. Annu Rev Physiol, 2008, 70 : 301-327.
  • 5Elkjaer M, Vajda Z, Nejsum LN, et al. Immunoloealization of AQP9 in liver, epididymis, testis, spleen, and brain [J]. Biochem Biophys Res Commun ,2000,276 ( 3 ) : 1118-1128.
  • 6Ishibashi K, Kuwahara M, Gu Y, et al. Cloning and functional expression of a new aquaporin ( AQP9 ) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol J]. Biochem Biophys Res Commun, 1998, 244 ( 1 ) : 268-274.
  • 7Ford P, Merot J, Jawerbanm A, et al. Water permeability in rat oocytes at different maturity stages : aquaporin-9 expression [ J ]. J Membr Biol,2000,176(2) :151-158.
  • 8Reshef L, Olswang Y, Cassuto H, et al. Glyeeroneogenesis and the triglyceride/fatty acid cycle [ J ]. J Biol Chem, 2003,278 ( 33 ) : 30413-30016.
  • 9Madeira A, Moura TF, Soveral G. Aquaglyceroporins : implications in adipose biology and obesity [ J ]. Cell Mol Life Sci, 2015, 72(4) :759-771.
  • 10Qiu LW, Gu LY, Lu L, et al. FOXOl-mediated epigenetic modifi- cations are involved in the insulin-mediated repression of hepato- cyte aquaporin 9 expression [ J ]. Mol Med Rep, 2015,11 ( 4 ) : 3064-3068.

引证文献6

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部